Kala Pharmaceuticals (KALA) Corporate Presentation - Slideshow

Innovation In Ophthalmics Corporate Overview August 2020 NOT FOR PROMOTIONAL USE 2 Disclaimers and Notices This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties, including statements regarding INVELTYS® and its commercial progress, the Company's lead product candidate, EYSUVISTM, for the short-term relief of the signs and symptoms of dry eye disease, including expectations regarding t ...